TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently.
Kim HS, Kim BR, Dao TTP, Kim JM, Kim YJ, Son H, Jo S, Kim D, Kim J, Suh YJ, Kim HJ, Cho BS, Park S.
Kim HS, et al. Among authors: kim br, kim yj, kim hj, kim jm, kim d, kim j.
Blood Adv. 2023 Jul 11;7(13):3155-3168. doi: 10.1182/bloodadvances.2022007956.
Blood Adv. 2023.
PMID: 36809797
Free PMC article.